Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
Abroad (travel likely)RecruitingPHASE2
Conditions
Esophageal Cancer · Gastrointestinal Cancers · Gynecologic Cancers
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Clemments University Hospital, Dallas, Texas, United States
Contact: Study coordinator (Cesia Rodriguez) · cesia.rodriguezgongora@UTSouthwestern.edu · 214-645-5799Contact: Principal Investigator (John Waters, M.D.)
Study leads
John Waters, M.D.
Principal Investigator
University of Texas Southwestern Medical Center